Results
eNauka >
Results >
1-year follow-up of a phase III study to compare efficacy and safety of a bevacizumab biosimilar, CT-P16, and reference bevacizumab as first-line treatment for metastatic or recurrent non-squamous non-small cell lung cancer
| Title: | 1-year follow-up of a phase III study to compare efficacy and safety of a bevacizumab biosimilar, CT-P16, and reference bevacizumab as first-line treatment for metastatic or recurrent non-squamous non-small cell lung cancer | Authors  : | Verschraegen, Claire; Andric, Zoran G; ...; (broj, koautora 20) | Issue Date: | 2022 | Publication: | ANNALS OF ONCOLOGY | ISSN: | 0923-7534 Annals of Oncology Search Idenfier |
Type: | Conference Paper | Collation: | vol. 33 br. 7 str. S1024-S1025 | DOI: | 10.1016/j.annonc.2022.07.1153 | WoS-ID: | 000866211601292 | URI: | https://enauka.gov.rs/handle/123456789/823166 | Project: | Celltrion Inc. | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | Mp. category will be shown later |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.